154 related articles for article (PubMed ID: 8938312)
1. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.
Ray DE; Cavanagh JB; Nolan CC; Williams SC
AJNR Am J Neuroradiol; 1996 Feb; 17(2):365-73. PubMed ID: 8938312
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats.
Ray DE; Holton JL; Nolan CC; Cavanagh JB; Harpur ES
AJNR Am J Neuroradiol; 1998 Sep; 19(8):1455-62. PubMed ID: 9763378
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Bøkenes J; Hustvedt SO; Refsum H
Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
[TBL] [Abstract][Full Text] [Related]
4. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction.
Li HT; Saeed M; Wendland MF; Higgins CB
Invest Radiol; 1993 Jan; 28(1):11-9. PubMed ID: 8425847
[TBL] [Abstract][Full Text] [Related]
6. An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
La Noce A; Miragoli L; Samuelli G; Tirone P
Invest Radiol; 1996 Sep; 31(9):550-5. PubMed ID: 8877491
[TBL] [Abstract][Full Text] [Related]
7. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Ball MJ; Ramsey F; Neuwelt EA
AJNR Am J Neuroradiol; 1991; 12(5):885-90. PubMed ID: 1950917
[TBL] [Abstract][Full Text] [Related]
8. Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium.
Berthezène Y; Mühler A; Lang P; Shames DM; Clément O; Rosenau W; Kuwatsuru R; Brasch RC
J Magn Reson Imaging; 1993; 3(1):125-30. PubMed ID: 8428078
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs.
Skalpe IO; Tang GJ
Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126
[TBL] [Abstract][Full Text] [Related]
10. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
[TBL] [Abstract][Full Text] [Related]
11. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
Alhassan A; Weinmann HJ
AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
[No Abstract] [Full Text] [Related]
12. Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart.
Akre BT; Dunkel JA; Hustvedt SO; Refsum H
Acad Radiol; 1997 Apr; 4(4):283-91. PubMed ID: 9110026
[TBL] [Abstract][Full Text] [Related]
13. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
McAlister WH; McAlister VI; Kissane JM
AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
[TBL] [Abstract][Full Text] [Related]
14. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W
Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
[TBL] [Abstract][Full Text] [Related]
15. Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction.
Mathews VP; Monsein LH; Pardo CA; Bryan RN
AJNR Am J Neuroradiol; 1994 Mar; 15(3):573-9. PubMed ID: 8197960
[TBL] [Abstract][Full Text] [Related]
16. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
17. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
Meyers SP; Wildenhain S; Chess MA; Tarr RW
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
[TBL] [Abstract][Full Text] [Related]
18. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
20. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
Brasch RC; Schwickert HC; Roberts TP; Shames DM; van Dijke CF; Mann JS; Demsar F
Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
